Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
2.

Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.

Sandoval-Borrego D, Moreno-Lafont MC, Vazquez-Sanchez EA, Gutierrez-Hoya A, López-Santiago R, Montiel-Cervantes LA, Ramírez-Saldaña M, Vela-Ojeda J.

Arch Med Res. 2016 Jan;47(1):55-64. doi: 10.1016/j.arcmed.2016.02.001.

PMID:
26876298
3.

Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.

Dauguet N, Récher C, Demur C, Fournié JJ, Poupot M, Poupot R.

Am J Hematol. 2011 Feb;86(2):209-13. doi: 10.1002/ajh.21906.

4.

Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.

Hadaya K, Avila Y, Valloton L, de Rham C, Bandelier C, Ferrari-Lacraz S, Pascual M, Pantaleo G, Martin PY, Buhler L, Villard J.

Clin Immunol. 2010 Nov;137(2):250-60. doi: 10.1016/j.clim.2010.07.004.

PMID:
20719569
5.
6.

Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.

Vuletić A, Jurišić V, Jovanić I, Milovanović Z, Nikolić S, Konjević G.

J Surg Res. 2013 Aug;183(2):860-8. doi: 10.1016/j.jss.2013.02.025.

PMID:
23522458
7.

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P.

Blood. 2003 May 1;101(9):3730-40.

8.

Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.

Kopp LM, Ray A, Denman CJ, Senyukov VS, Somanchi SS, Zhu S, Lee DA.

Mol Immunol. 2013 Jul;54(3-4):296-301. doi: 10.1016/j.molimm.2012.12.012.

PMID:
23328088
9.

Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.

Mantegani P, Tambussi G, Galli L, Din CT, Lazzarin A, Fortis C.

Immunology. 2010 Feb;129(2):220-33. doi: 10.1111/j.1365-2567.2009.03171.x.

10.

HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.

Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD, et al.

Blood. 1994 Jul 1;84(1):244-55.

11.

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.

Stringaris K, Sekine T, Khoder A, Alsuliman A, Razzaghi B, Sargeant R, Pavlu J, Brisley G, de Lavallade H, Sarvaria A, Marin D, Mielke S, Apperley JF, Shpall EJ, Barrett AJ, Rezvani K.

Haematologica. 2014 May;99(5):836-47. doi: 10.3324/haematol.2013.087536.

12.

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.

Curti A, Ruggeri L, D'Addio A, Bontadini A, Dan E, Motta MR, Trabanelli S, Giudice V, Urbani E, Martinelli G, Paolini S, Fruet F, Isidori A, Parisi S, Bandini G, Baccarani M, Velardi A, Lemoli RM.

Blood. 2011 Sep 22;118(12):3273-9. doi: 10.1182/blood-2011-01-329508.

13.

Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.

Norris S, Doherty DG, Curry M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C.

Cancer Immunol Immunother. 2003 Jan;52(1):53-8.

PMID:
12536240
14.

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect.

Nguyen S, Dhedin N, Vernant JP, Kuentz M, Al Jijakli A, Rouas-Freiss N, Carosella ED, Boudifa A, Debré P, Vieillard V.

Blood. 2005 May 15;105(10):4135-42.

15.

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E.

J Hepatol. 2009 Sep;51(3):458-67. doi: 10.1016/j.jhep.2009.05.030.

PMID:
19596474
17.

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

Hadaya K, de Rham C, Bandelier C, Bandelier C, Ferrari-Lacraz S, Jendly S, Berney T, Buhler L, Kaiser L, Seebach JD, Tiercy JM, Martin PY, Villard J.

Am J Transplant. 2008 Dec;8(12):2674-83. doi: 10.1111/j.1600-6143.2008.02431.x.

19.

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.

Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, Wiktor-Jedrzejczak W, Kalberer CP, Wodnar-Filipowicz A.

Blood. 2008 Feb 1;111(3):1428-36.

20.

Activation of natural killer cells by hepatitis C virus particles in vitro.

Farag MM, Weigand K, Encke J, Momburg F.

Clin Exp Immunol. 2011 Sep;165(3):352-62. doi: 10.1111/j.1365-2249.2011.04431.x.

Items per page

Supplemental Content

Support Center